Losses to the extreme and it has taken 5-6 years for those...

Losses to the extreme and it has taken 5-6
years for those responsible to exit. Besides
them all financially benefitting at the huge
expense and losses to shareholders. The
Broking firm which did Teva capital raising rated
this their number one deal for the year. Their
manager told me personally that fact. They are
also a very large company. They and their staff
would have made massive sums on the way up
then again on the way down . This company has
been a disaster to me . The way banks are requiring
security on funds now ( particularly in USA ) the
timing of the Catalent deal may be a Godsend. This
is why excess funds are never really excess. They
have as KP alluded to really sold the main farm. This
security in itself would have enabled lower rates on
bank $$$ costs. Last year alone $32m plus. Our net
debt was continually rising under Richards. It still amazes
me how he was allowed to keep destroying the company
He was just a verbal diatribe spruking incompetent
idiot . His company management skills in every area
has been shown to be a failure to shareholders but
all staff reviews I have read none ever complain about
salary or wages. The opposite actually praising most
happy. Just as an example the $100m allocated to SD
would acquire 20% plus of Mithra. We could have 1
or 2 board members and secure distribution rights for their future Menopause medication currently undertaking
phases for FDA approval. This area of Pharma would
make Nextellis appear tiny. Obviously extreme due
diligence required. Mithra was a 1 billion Euro company
earlier this year but they have cash flow problems.
My point is mainly a SD should only happen in a
ASX blue chip company with no future risks. I don’t
believe Mayne is that.